year 17, Issue 6 (November - December 2023)                   Iran J Med Microbiol 2023, 17(6): 646-653 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nakhaie M, Ahmadinejad Farsangi S, Rezaei Zadeh Rukerd M, Shafieipour S, Arefinia N, Zahedi M J, et al . Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023). Iran J Med Microbiol 2023; 17 (6) :646-653
URL: http://ijmm.ir/article-1-2132-en.html
1- Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
2- Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences Kerman, Iran
3- Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
4- Student Research Committee Jiroft University of Medical Sciences, Jiroft, Iran
5- Department of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
6- Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences Kerman, Iran
7- Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , j.4ostad@gmail.com
Abstract:   (480 Views)

Background and Aim: Viral infections are associated with augmented morbidity and mortality risk in Hemodialysis (HD) patients.
Materials and Methods: In this investigation, we have scrutinized the presence of hepatitis B virus (HBV), and occult hepatitis B virus infection (OBI), in HD patients. In this cross-sectional study, the blood samples and data from 200 hemodialysis patients referred to a dialysis center in Kerman, from January 2022 to March 2023 were collected. Anti-HBV antibodies and HBs Ag were analyzed in the specimens using an enzyme-linked immunosorbent assay (ELISA). All samples were tested for OBI by using a real-time polymerase chain reaction (PCR) assay.
Results: Of the 200 patients considered, 4 (2%) for HBs Ag were positive. Real-time PCR demonstrated OBI in 2 (1%) patients. The majority presence of viral infection was in the age group 50≥ years, self-employment, low education level, and diabetic patients. Furthermore, our study revealed that a higher percentage of HD patients were associated with low educational levels, self-employment, urban residence, and comorbidities such as diabetes and hypertension.
Conclusion: In this study, HBV antigen prevalence was 2%, and OBI prevalence was 1%, indicating a low HBV incidence in HD patients. Our study underscores the importance of lifestyle improvement, increased awareness among lower-educated and lower-skilled individuals, and rigorous disinfection practices in managing risk factors for hemodialysis patients, including HBV and OBI.

Full-Text [PDF 567 kb]   (156 Downloads) |   |   Full-Text (HTML)  (44 Views)  
Type of Study: Original Research Article | Subject: Medical Virology
Received: 2023/07/22 | Accepted: 2023/10/29 | ePublished: 2024/01/29

References
1. Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607-28. [DOI:10.1016/j.cld.2016.06.006] [PMID] [PMCID]
2. Mokhtari F, Kaboosi H, Mohebbi SR, Asadzadeh Aghdaei H, Zali MRZ. Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker. Iran J Med Microbiol. 2022;16(6):543-50. [DOI:10.30699/ijmm.16.6.543]
3. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(4):e35577. [DOI:10.5812/hepatmon.35577]
4. Zahedi MJ, Shafieipour S, Hayatbakhsh Abbasi MM, Nakhaie M, Rezaei Zadeh Rukerd M, Lashkarizadeh MM, et al. Mortality Trends of Gastrointestinal, Liver, and Pancreaticobiliary Diseases: A Hospital-Based Prospective Study in the Southeast of Iran. Middle East J Dig Dis. 2022;14(4):404-9. [DOI:10.34172/mejdd.2022.301] [PMID] [PMCID]
5. Mehmandoost S, Khezri M, Mousavian G, Tavakoli F, Mehrabi F, Sharifi H, et al. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis. Public Health. 2022;203:75-82. [DOI:10.1016/j.puhe.2021.11.020] [PMID]
6. Thijssen M, Tacke F, Van Espen L, Cassiman D, Naser Aldine M, Nevens F, et al. Plasma virome dynamics in chronic hepatitis B virus infected patients. Front Microbiol. 2023;14:1172574. [DOI:10.3389/fmicb.2023.1172574] [PMID] [PMCID]
7. Sterling RK, Wahed AS, Cloherty G, Hoofnagle JH, Lee WM. Acute Hepatitis B Virus Infection in North American Adults. Clin Gastroenterol Hepatol. 2023;21(7):1881-92.e4. [DOI:10.1016/j.cgh.2022.09.004] [PMID] [PMCID]
8. Saedi E, Derakhshan M, Shamsian AA, Tahaghoghi Hajghorbani S, Movaqar A, Youssefi M. A Lamivudine/ Entacavir Resistance Mutations Among Treatment Naïve Chronic HBV Infected Patients Mashhad, Iran. Iran J Med Microbiol. 2022;16(5):376-82. [DOI:10.30699/ijmm.16.5.376]
9. El-Mowafy M, Elegezy M, El-Mesery M, Elgaml A. Novel method for cloning of hepatitis B virus DNA using the In-Fusion enzyme. Gene Reports. 2023;31:101765. [DOI:10.1016/j.genrep.2023.101765]
10. Jang JW, Lee SW, Nam H, Lee SK. Chapter 22 - Hepatitis: infections and systemic causes. In: Seto W-K, Eslam M, editors. Comprehensive Guide to Hepatitis Advances: Academic Press; 2023. p. 487-524. [DOI:10.1016/B978-0-323-98368-6.00016-1]
11. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol. 2011;17(2):87-95. [DOI:10.3350/kjhep.2011.17.2.87] [PMID] [PMCID]
12. Hashemi SMA, Hashemzadeh F, Bahrampour H, Nekoei F, Joharinia N, Sarvari J. The Evaluation Anti-HBsAb Titer Among University Students in Shiraz, 2019. Iran J Med Microbiol. 2020;14(4):297-306. [DOI:10.30699/ijmm.14.4.297]
13. M.R. Ibrahim N, Sidiq Mohammed Saleem Z, R Hussein N. The Prevalence of HIV, HCV, and HBV Among Hemodialysis Patients Attending Duhok Hemodialysis Center. Int J Infect. 2018;5(1):e63246. [DOI:10.5812/iji.63246]
14. Mhalla S, Hammoud R, Frih A, Kadri Y, El Argoubi A, Elmay M, et al. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia. Med Mal Infect. 2018;48(3):175-9. [DOI:10.1016/j.medmal.2017.11.006] [PMID]
15. Duong MC, Nguyen VTT, Otsu S, McLaws M-L. Prevalence of hepatitis B and C virus infections in hemodialysis patients in Vietnam: A systematic review and meta-analysis. JGH Open. 2020;4(1):29-38. [DOI:10.1002/jgh3.12199] [PMID] [PMCID]
16. Djalalinia S, Ramezan Ghorbani N, Tajbakhsh R, Modirian M, Esmaeili Abdar Z, Mahdavi Gorabi A, et al. Hepatitis B Virus Infection in Iranian Hemodialysis Patients: a Systematic Review and Meta-Analysis. Iran J Kidney Dis. 2018;12(1):1-9.
17. Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol. 2016;22(39):8720-34. [DOI:10.3748/wjg.v22.i39.8720] [PMID] [PMCID]
18. Soleimanpour S, Hedayati-Moghaddam MR, Farshchian M, Rezaee SA, Mosavat A. Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study. J Virus Erad. 2023;9(2):100333. [DOI:10.1016/j.jve.2023.100333] [PMID] [PMCID]
19. Candotti D, Allain J-P. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51(4):798-809. [DOI:10.1016/j.jhep.2009.05.020] [PMID]
20. Hedayati-Moghaddam MR, Soltanian H, Behzadifar M. Occult Hepatitis B Virus Infection Prevalence Among Different Populations of Iran: A Systematic Review and Meta-Analysis. Hepat Mon. 2020;20(6):e101722. [DOI:10.5812/hepatmon.101722]
21. Gutiérrez-García ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011;17(12):1538-42. [DOI:10.3748/wjg.v17.i12.1538] [PMID] [PMCID]
22. Kim H, Lee SA, Won YS, Lee H, Kim BJ. Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity. World J Gastroenterol. 2015;21(6):1794-803. [DOI:10.3748/wjg.v21.i6.1794] [PMID] [PMCID]
23. Zhang Y-L, Cheng T, Cai Y-J, Yuan Q, Liu C, Zhang T, et al. RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo. BMC Microbiol. 2010;10(1):214. [DOI:10.1186/1471-2180-10-214] [PMID] [PMCID]
24. Wang X, Zhao Y, Xiao Z, Chen B, Wei Z, Wang B, et al. Alternative Translation of OCT4 by an Internal Ribosome Entry Site and its Novel Function in Stress Response. Stem Cells. 2009;27(6):1265-75. [DOI:10.1002/stem.58] [PMID]
25. Mohammadi Z, Keshtkar A, Eghtesad S, Jeddian A, Pourfatholah AA, Maghsudlu M, et al. Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies. Middle East J Dig Dis. 2016;8(1):5-18. [DOI:10.15171/mejdd.2016.01] [PMID] [PMCID]
26. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12(5):339-43. [DOI:10.5812/hepatmon.5969] [PMID] [PMCID]
27. Xiang H, Li M, Xiao M, Liu M, Su X, Wang D, et al. Factors associated with risk behaviours towards hepatitis B among migrant workers: a cross-sectional study based on theory of planned behaviour. BMJ Open. 2022;12(9):e056452. [DOI:10.1136/bmjopen-2021-056452] [PMID] [PMCID]
28. Mohammed H, Eshetie A, Melese D. Prevalence of hepatitis B virus and associated risk factors among adults patients at Dessie referral and Kemise general hospitals in northeastern Ethiopia. Health Sci Rep. 2022;5(3):e659. [DOI:10.1002/hsr2.659] [PMID] [PMCID]
29. Mohaghegh Shelmani H, Karayiannis P, Ashtari S, Mahmanzar MA, Khanabadi B, Modami N, et al. Demographic changes of hepatitis B virus infection in Iran for the last two decades. Gastroenterol Hepatol Bed Bench. 2017;10(Suppl1):S38-s43.
30. Weis-Torres SMdS, Fitts SMF, Cardoso WM, Higa Junior MG, Lima LA, Bandeira LM, et al. High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage. Int J Infect Dis. 2020;90:46-52. [DOI:10.1016/j.ijid.2019.09.029] [PMID]
31. Al-Ghamdi SMG, Bieber B, AlRukhaimi M, AlSahow A, Al Salmi I, Al Ali F, et al. Diabetes Prevalence, Treatment, Control, and Outcomes Among Hemodialysis Patients in the Gulf Cooperation Council Countries. Kidney Int Rep. 2022;7(5):1093-102. [DOI:10.1016/j.ekir.2022.02.012] [PMID] [PMCID]
32. Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of chronic hepatitis B virus infection in the United States. Am J Gastroenterol. 2020;115(9):1429-38. [DOI:10.14309/ajg.0000000000000651] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc